Branched chain ketoacid decarboxylation is defective in
**Core Concept**
Branched-chain ketoacid decarboxylation is a critical metabolic pathway involved in the breakdown of branched-chain amino acids (BCAAs), including leucine, isoleucine, and valine. This process occurs primarily in the liver and is essential for maintaining nitrogen balance and preventing the accumulation of toxic intermediates.
**Why the Correct Answer is Right**
The correct answer is related to the enzyme responsible for the decarboxylation step in the metabolism of BCAAs. This enzyme, branched-chain alpha-ketoacid dehydrogenase (BCKAD), is a key player in this pathway. A deficiency in BCKAD leads to the accumulation of branched-chain alpha-ketoacids, resulting in a condition known as maple syrup urine disease (MSUD). MSUD is characterized by the presence of a characteristic sweet odor in the urine, as well as neurological and developmental abnormalities.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not relate to the specific defect in branched-chain ketoacid decarboxylation.
**Option B:** This option is incorrect as it refers to a different metabolic pathway, not directly related to BCAA metabolism.
**Option C:** This option is incorrect as it refers to a different type of enzyme deficiency, not related to the decarboxylation step in BCAA metabolism.
**Clinical Pearl / High-Yield Fact**
Maple syrup urine disease (MSUD) is a classic example of a metabolic disorder caused by a defect in a specific enzyme in the BCAA metabolism pathway. It is essential to recognize the characteristic sweet odor in the urine as a diagnostic clue for this condition.
**Correct Answer: D. Maple syrup urine disease**